Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
bi-d1870 ribosomal protein s6 kinase alpha-1 NA Patented-recorded target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Chronic Lymphocytic Leukemia[MeSHID:D015451]		 4.55 preclinical unknown
bi-d1870 ribosomal protein s6 kinase alpha-1 NA Patented-recorded target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Chronic Lymphocytic Leukemia[MeSHID:D015451]		 4.55 preclinical inhibitor
bi-d1870 ribosomal protein s6 kinase alpha-2 NA Literature-reported target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Chronic Lymphocytic Leukemia[MeSHID:D015451]		 31.83 preclinical inhibitor
bi-d1870 ribosomal protein s6 kinase alpha-2 NA Literature-reported target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Chronic Lymphocytic Leukemia[MeSHID:D015451]		 31.83 preclinical unknown
bi-d1870 ribosomal protein s6 kinase alpha-3 NA Patented-recorded target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Chronic Lymphocytic Leukemia[MeSHID:D015451]		 0.94 preclinical unknown
bi-d1870 ribosomal protein s6 kinase alpha-3 NA Patented-recorded target TTD , DGIDB Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Chronic Lymphocytic Leukemia[MeSHID:D015451]		 0.94 preclinical inhibitor
click here to return to the previous page